(Reuters) -British pharmaceutical giant GSK has not met required ethical and regulatory standards in its marketing and prescription information for its Omjjara drug, an industry self-regulatory body ...

A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a midstage ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial, according to ...

New Delhi: A new pill has shown promise against antibiotic-resistant gonorrhoea -- a common sexually transmitted infection (STI) --, according to a study published in the journal The Lancet.

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...

Pfizer said on Monday it has discontinued development of experimental weight-loss pill danuglipron after a trial patient ...

In a significant breakthrough in the fight against antibiotic-resistant sexually transmitted infections (STIs), a new oral pill, gepotidacin, has shown promising results in combating drug-resistant ...

Gonorrhea is on the verge of incurability, with just one antibiotic that still reliably works against the sexually ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea. It could be the first new type of ...

Johnson & Johnson on Tuesday reported first-quarter revenue and profit above Wall Street estimates, driven again by strong sales of its cancer treatments including multiple myeloma medicine Darzalex.

Scientists have found the first new antibiotic treatment for gonorrhoea since the 1990s amid fears over the rise of ...